KNSA
Kiniksa Pharmaceuticals Ltd
75.20$
+0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 99.2% | 97.4% | 94.9% | 95.4% | 84.4% | 52.9% | 52.5% | 57.2% | 69.0% | |
| 99.1% | 95.9% | 95.4% | 18.4% | 32.6% | 52.6% | 26.7% | 20.5% | 31.6% | 21.7% | |
| 99.1% | 95.9% | 95.4% | 91.7% | 92.6% | 78.3% | 41.5% | 39.2% | 42.0% | 54.2% | |
| – | – | – | – | 0.0% | 1.7% | 4.4% | 4.0% | 7.2% | 2.0% | |
| – | – | – | – | 0.0% | 1.6% | 4.7% | 5.9% | 4.5% | 7.2% | |
| 0.1% | 0.3% | 2.0% | 3.3% | 1.2% | 1.2% | 0.4% | – | – | – | |
| – | – | – | – | – | 8.3% | 4.0% | 3.3% | 2.8% | 2.0% | |
| 145.6% | 288.9% | 13.3% | 11.4% | 10.7% | 20.5% | 13.8% | 16.6% | 24.5% | 25.7% | |
| 4.1% | 36.7% | 13.2% | 10.9% | 9.1% | 19.3% | 10.2% | 12.1% | 17.3% | 18.2% | |
| – | – | – | 0.7% | 0.6% | 1.5% | 0.7% | 0.4% | 0.3% | 0.4% | |
| 0.4% | 2.6% | 3.4% | 2.2% | 0.1% | 0.8% | 1.7% | 1.6% | 0.4% | 0.3% | |
| -45.6% | -188.9% | -60.3% | 88.6% | 89.3% | 79.5% | 86.2% | 83.4% | 75.5% | 74.3% | |
| -46.3% | -191.6% | -60.3% | -139.9% | -148.1% | -290.1% | -107.0% | -90.8% | -89.8% | -60.5% | |
| 57.5% | 68.4% | 9.2% | 21.2% | 17.7% | 29.5% | 15.3% | 13.7% | 12.3% | 10.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.